US Stock MarketDetailed Quotes

AZN AstraZeneca

Watchlist

78.425
-0.535-0.68%

Trading Sep 13 10:22 ET

243.16BMarket Cap38.07P/E (TTM)

AstraZeneca Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

AstraZeneca Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2024/Q4	-- / 13.478B	--
--	2024/Q3	-- / 12.997B	--
--	2024/Q2	12.938B / 12.528B	--
Apr 25, 2024	2024/Q1	12.679B / 11.812B	--
--	2023/Q4	12.024B / 12.007B	--

DatePeriodRevenue/EstimateEarnings Call

--2024/Q4-- / 13.478B--

--2024/Q3-- / 12.997B--

--2024/Q212.938B / 12.528B--

Apr 25, 20242024/Q112.679B / 11.812B--

--2023/Q412.024B / 12.007B--

Unlock Free Earnings Estimates

Open Account

AstraZeneca Earnings Reports

6-K: H1 and Q2 2024 Results

Jul 25 09:09 ET

AstraZeneca | 6-K: AstraZeneca to Deliver $80bn Revenue by 2030

May 21 06:10 ET

6-K: Q1 2024 Results

Apr 25 06:29 ET

AstraZeneca | 6-K: Closure of Notes Sale Pursuant to Underwriting Agreement

Feb 26 16:10 ET

Analyst Rating

Updated: Sep 13, 2024

Strong Buy

Buy
100.00%
Hold
0.00%
Sell
0.00%

Price Target

No Data

Heat List

Overall